
The AIQ Imperative: A New Competitive Paradigm for BioPharma
Artificial intelligence is redrawing the boundaries of what’s possible in drug development. For decades, the pharma business model has been built on delivering human intelligence as a service. Study teams from CROs, sites and sponsors have been the …